
To investigate the dosing patterns and treatment costs of zzso agents in adult zzso 18 years of zzso cancer patients newly initiated on zzso zzso zzso or zzso zzso zzso in managed care zzso 

An analysis of US medical claims (30 million lives in over 35 health zzso in the period July 1, zzso 28, 2005 was zzso Patients with zzso 1 cancer claim within 90 days prior to initiating EPO or zzso and who received at least two doses of the same zzso agent, were included in this zzso zzso average weekly zzso cumulative treatment dose, associated drug cost, dosing frequency patterns, and the frequency of zzso visits were zzso The zzso dose ratio, based on average cumulative treatment doses, was zzso 

zzso EPO and zzso zzso patients met the inclusion and exclusion zzso The EPO group was older zzso zzso years; zzso zzso years; p zzso zzso with a higher proportion of men zzso zzso zzso zzso p zzso zzso zzso dosing frequency was observed with similar treatment zzso for the two groups zzso EPO zzso zzso zzso p zzso zzso A dose ratio of zzso was observed zzso cumulative zzso EPO 252 zzso zzso zzso zzso zzso Average drug cost was significantly higher in the zzso group zzso zzso EPO zzso dollars; zzso zzso dollars; p zzso zzso The average number of zzso zzso visits per patient zzso EPO zzso zzso zzso p zzso zzso and zzso visits for zzso determination zzso EPO zzso zzso zzso p zzso zzso during treatment was similar between the two zzso 

The results were based on medical claims zzso The absence of information on actual injection dates in pharmacy claims prevented their incorporation in the zzso 

Based on the average cumulative doses, the zzso dose ratio was zzso zzso zzso zzso zzso with zzso greater drug cost in the zzso zzso Despite the variable administration frequency observed between the two agents, the number of zzso zzso visits was not zzso 

